Footnotes
- C1: Drug is in the Controlled Drugs and Substances Act and Part I of the Schedule to Part G of the Food and Drug Regulations}
- C2: Drug is in the Controlled Drugs and Substances Act and Part II of the Schedule to Part G of the Food and Drug Regulations
- C3: Drug is in the Controlled Drugs and Substances Act and Part III of the Schedule to Part G of the Food and Drug Regulations
- C4: drug is in the Controlled Drugs and Substances Act
- C5: drug is in the Regulations Under CDSA
- CR: drug has been recommended for addition to the Controlled Drugs and Substances Act
- CR-C: drug has been recommended for addition to the Controlled Drugs and Substances Act, Part G of the Food and Drug Regulations
- CR-N: drug has been recommend for addition to the Controlled Drugs and Substances Act, Narcotic Control Regulations
- CR-TS: drug has been recommended for addition to the Controlled Drugs and Substances Act, Benzodiazepines and Other Targeted Substances Regulations
- F1: drug appears in Part I of Schedule F to the Food and Drugs Act and Regulations
- F2: drug appears in Part II of Schedule F to the Food and Drugs Act and Regulations
- FR: drug has been recommended for addition to Schedule F to the Food and Drugs Act and Regulations ("Schedule F Recommended")
- N: drug is in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
- NR: drug has not been reviewed by NDSAC
- PDL: drug is in the Prescription Drug List (effective Dec. 19, 2013)
- R: drug is in Part J of the Food and Drus Act and listed in the Controlled Drugs and Substances Act
- TS: drug is in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
- U: drug has been reviewed by NDSAC and is unscheduled